# Readiness to Use Medicinal Marijuana in the Practices of Polish Family Physicians – MDPI > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/readiness-to-recommend-medicinal-cannabis-polish-family-physicians/ > **Published:** 2026-04-01T09:22:36-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:33:02-04:00 > **Clinical Summary:** Explore the readiness to recommend medicinal cannabis among Polish family physicians and the barriers impacting clinical adoption despite legalization. --- ✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyResearchSafetyMental Health Why This Matters Polish family physicians show limited readiness to recommend medicinal cannabis despite its legal status, which creates a gap between regulatory allowance and clinical practice that may leave patients without evidence-based guidance on this treatment option. Understanding physician attitudes and barriers to cannabis prescribing is essential for developing training and policy that could improve patient access to potentially beneficial treatments while ensuring safe, informed use. This readiness assessment directly informs how clinicians can integrate cannabis into their therapeutic toolkit and what educational interventions might increase appropriate prescribing in countries with similar regulatory frameworks. Clinical Summary # Clinical Summary Despite legalization of medicinal cannabis in Poland in 2017, this study examined the readiness of family physicians to incorporate cannabis into clinical practice and found significant gaps in provider confidence and knowledge. The research identifies barriers to implementation including insufficient training, uncertainty about appropriate indications, concerns regarding efficacy and safety data, and lack of clinical experience among primary care physicians who are often patients’ first point of contact. These findings highlight a critical disconnect between legal availability and clinical adoption, which may result in delayed treatment access or inappropriate self-management by patients seeking alternatives for conditions like [chronic pain](https://cedclinic.com/cannabinoids-pain-management-opioid-alternative/) and neuropathy. The study underscores that regulatory approval alone does not ensure clinical integration without accompanying physician education and evidence-based guidance. For clinicians, this suggests the need for targeted training programs and accessible clinical protocols to bridge knowledge gaps and build confidence in appropriate cannabis prescribing. Patients in jurisdictions with legal cannabis may benefit from seeking care from providers who have pursued specific education in cannabinoid therapeutics, or from physician-led initiatives to systematically educate primary care practitioners about patient selection and dosing. Dr. Caplan’s Take “What we’re seeing in Poland mirrors what happened here in the States: physicians want to prescribe thoughtfully, but we lack the clinical training and evidence base to do it well, so we default to caution or referral. The solution isn’t more permissiveness or more restriction, it’s building competency through structured education so family doctors can actually assess cannabinoid therapy the way we assess any other medication.” Clinical Perspective While medicinal cannabis legalization in Poland expanded patient access in 2017, this survey reveals significant hesitancy among family physicians to integrate it into clinical practice, reflecting broader uncertainty about efficacy, safety, and appropriate indications that extends beyond Poland. Clinicians’ readiness to recommend cannabis appears influenced by knowledge gaps, regulatory ambiguity, and limited clinical guidelines rather than outright ideological opposition, suggesting that education and evidence synthesis could shift practice patterns. Important confounders include variable training in cannabinoid pharmacology, heterogeneous product formulations available in different jurisdictions, and the challenge of extrapolating evidence from research studies to individual patient contexts with comorbidities and polypharmacy. For family physicians encountering patients interested in medicinal cannabis, acknowledging the current evidence base for specific conditions (such as chemotherapy-induced nausea or certain seizure disorders), maintaining awareness of knowledge limitations in other areas, and engaging in shared 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+Readiness+to+Use+Medicinal+Marijuana+in+the+Practices+of+Polish+Family+Physicians+-+MDPI+%40drcaplan&url=https%3A%2F%2Fwww.mdpi.com%2F2077-0383%2F15%2F7%2F2670)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fwww.mdpi.com%2F2077-0383%2F15%2F7%2F2670)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+Readiness+to+Use+Medicinal+Marijuana+in+the+Practices+of+Polish+Family+Physicians+-+MDPI+--+via+%40drcaplan.bsky.social+https%3A%2F%2Fwww.mdpi.com%2F2077-0383%2F15%2F7%2F2670)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.mdpi.com/2077-0383/15/7/2670](https://www.mdpi.com/2077-0383/15/7/2670) Further Reading Research Digest[Research Digest: 5 Recent Studies – March 25, 2026](https://cedclinic.com/research-digest-recent-studies-march-2026/) Evidence Watch[Association of Cannabis Use Disorder Versus Other Substance Use Disorders With Psychiatric Conditions: A Propensity-Matched Retrospective Cohort Analysis.](https://cedclinic.com/cannabis-use-disorder-psychiatric-risk-profile/) Cannabis Policy Wire[Policy Watch: 20 Regulatory Updates — March 20, 2026](https://cedclinic.com/drug-enforcement-controlled-substances-regulatory-policy-2026/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [After a hard-fought victory to legalise medical cannabis in the UK, why is it still so hard to access?](https://cedclinic.com/after-a-hard-fought-victory-to-legalise-medical-cannabis-in-the-uk-why-is-it-still-so-hard-to-access/) Explore the challenges patients face accessing medical cannabis in the UK despite legalization, highlighting regulatory and clinical barriers. [Learn More](https://cedclinic.com/after-a-hard-fought-victory-to-legalise-medical-cannabis-in-the-uk-why-is-it-still-so-hard-to-access/) [Research Limits on Knowledge of Benefit or Harm of Cannabis and Cannabinoids Use](https://cedclinic.com/research-limits-cannabis-benefits-harms/) Understand the current research gaps on cannabis benefits and risks, emphasizing the need for evidence-based clinical guidance. [Read Research](https://cedclinic.com/research-limits-cannabis-benefits-harms/) [Medical Marijuana: Delivering Clinical Care in an Ever-Evolving Environment Event Details](https://cedclinic.com/medical-marijuana-delivering-clinical-care-in-an-ever-evolving-environment-event-details/) Details on clinical care advancements and educational initiatives to improve medicinal cannabis integration in healthcare. [View Event](https://cedclinic.com/medical-marijuana-delivering-clinical-care-in-an-ever-evolving-environment-event-details/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).